INSIGHTS ON CLINICAL TRIAL DESIGN
-
Why We Need To Look To The Future Of Clinical Trials
Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.
-
RTSM Automating Adaptive Enrollment In Basket Trials
Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
Decentralized Clinical Trials: FDA Guidance Analyzed
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes5/22/2026
Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.
-
Rethinking Recruitment: Patient-Centric Strategies For The Future Of Clinical Trials9/30/2025
For sponsors and CROs, the message is clear: recruitment must be redesigned for accessibility, inclusivity, and patient trust.
-
Rapid Expansion Of Peptide And Nanobody Drug Conjugates7/21/2026
Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
-
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity3/28/2025
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
Why Operational Expertise Defines Great Clinical Trial Services9/4/2026
Great trial technology isn't enough on its own. See why the operational expertise behind it can make or break your study's success.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
-
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
-
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
Explore how a multi-omics strategy integrates genomics, transcriptomics, proteomics, spatialomics & pathomics to provide the deep biological insights needed to accelerate precision medicine and clinical development.